Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

39.95
-0.1500-0.37%
Post-market: 39.950.00000.00%19:30 EDT
Volume:587.80K
Turnover:23.31M
Market Cap:3.85B
PE:-20.42
High:40.20
Open:39.85
Low:38.90
Close:40.10
52wk High:42.68
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.74
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.21
PE(LYR):-31.09

Loading ...

IDEAYA Biosciences - to Initiate Phase 1 Combination Cohorts in Pdac and Nsclc

THOMSON REUTERS
·
Jun 03

IDEAYA Biosciences Price Target Maintained With a $58.00/Share by Wedbush

Dow Jones
·
Jun 02

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA), Vera Therapeutics (VERA) and Regeneron (REGN)

TIPRANKS
·
Jun 02

IDEAYA darovasertib-crizotinib combo cuts progression risk in Phase 2/3 OptimUM-02 metastatic uveal melanoma trial

Reuters
·
Jun 01

IDEAYA Biosciences and Servier Provide Complete Data From Phase 2/3 Registrational Optimum-02 Trial of the Darovasertib Combination in First Line Hla*a2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at Asco

THOMSON REUTERS
·
Jun 01

IDEAYA Biosciences grants 221,000 inducement stock options at USD 29.34 per share

Reuters
·
May 29

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 29

IDEAYA Biosciences to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 26

IDEAYA Biosciences (IDYA) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 10

Some Analysts Just Cut Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Estimates

Simply Wall St.
·
May 07

RBC Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)

TIPRANKS
·
May 06

IDEAYA Biosciences Files New Shelf Registration Statement

TIPRANKS
·
May 06

BRIEF-Ideaya Biosciences Inc - Enters Sales Agreement With Jefferies For Common Stock Offering Up To $350 Million - SEC Filing

Reuters
·
May 06

BRIEF-Ideaya Biosciences Inc Files For Mixed Shelf Offering, Size Not Disclosed- SEC Filing

Reuters
·
May 06

IDEAYA files prospectus for up to $156.6 million remaining at-the-market share sales

Reuters
·
May 06

IDEAYA Biosciences Inc Files for Mixed Shelf Offering, Size Not Disclosed- SEC Filing

THOMSON REUTERS
·
May 06

Analysts Are Bullish on Top Healthcare Stocks: Lineage Therap (LCTX), IDEAYA Biosciences (IDYA)

TIPRANKS
·
May 06

Ideaya Biosciences' Darovasertib Combination Data Profile is 'Highly Compelling,' Wedbush Says

MT Newswires Live
·
May 06

IDEAYA Biosciences Q1 EPS $(1.11) Misses $(0.98) Estimate, Sales $6.560M Beat $5.008M Estimate

Benzinga Earnings
·
May 05

IDEAYA Biosciences Q1 net loss widens, misses expectations on higher R&D spends

Reuters
·
May 05